Alternating high-risk human papillomavirus infection: Consequences of progression to cervical intraepithelial neoplasia

Cancer

Volumn 108, Issue 6, 2006, Pages 475-479

  Rijkaart, Dorien C ^a   Bontekoe, Tj Romke ^b   Korporaal, Hans ^a   Boon, Mathilde E ^a  

^a LEIDEN CYTOLOGY AND PATHOLOGY LABORATORY   (Netherlands)

^b Bontekoe Research   (Netherlands)

Author keywords

Alternating infection; Cervical intraepithelial neoplasia; Cervix; High risk human papillomavirus infection; HPV

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS EXAMINATION; VIRUS INFECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33846168470     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22305     Document Type: Article

References (28)

1. Melkert PW, Hopman E, van den Brule AJ, et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer. 1993;53:919-923.
2. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev. 2003;12:485-490.
3. Guiliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence and clearance of type-specific human papillomavirus infections: the young women health study. J Infect Dis. 2002;186:462-469.
4. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423-428.
5. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
6. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244-246.
7. Van den Brule AJC, Meijer CJLM, Bakels V, Kenemans P, Walboomers JM. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol. 1990;28:2739-2743.
8. Ting Y, Manos MM. Detection and typing of genital human papillomavirus. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR Protocols: A Guide to Methods and Applications. San Diego: Academic Press Inc.; 1990:356-367.
9. Wachtel MS, Boon ME, Korporaal H, Kok LP. Human papillomavirus testing as a cytology gold standard: comparing Surinam with The Netherlands. Mod Pathol. 2005;18:349-353.
10. Hinchliffe SA, van Velzen D, Korporaal H, Kok LP, Boon ME. Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology. Br J Cancer. 1995;72:943-945.
11. Castle PE, Shiffman M, Herrero R, et al. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis. 2005;191:1808-1816.
12. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol. 1996;88:261-268.
13. Woodman CBJ, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet. 2001;357:1831-1836.
14. Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis. 1996;174:679-689.
15. Maiman M, Fruchter RG. Cervical neoplasia and the human immunodeficiency virus. In: Rubin SC, Hoskins WJ, editors. Cervical Cancer and Preinvasive Neoplasia. Philadelphia: Lippincott-Raven; 1996:405-416.
16. Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362:1871-1876.
17. Morrison EA. Natural history of cervical infection with human papillomaviruses. Clin Infect Dis. 1994;18:172-180.
18. Sellors JW, Karwalajtys TL, Kaxzorowski J, et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ. 2003;168:421-425.
19. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327:1272-1278.
20. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995;87:1365-1371.
21. Remmink AJ, Walboomers JM, Helmerhorst TJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer. 1995;61:306-311.
22. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999;354:20-25.
23. Rozendaal L, Walboomers JM, van der Linden JC, et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer. 1996;68:766-769.
24. Rozendaal L, Westerga J, van der Linden JC, et al. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes. J Clin Pathol. 2000;53:606-611.
25. Bulkmans NWJ, Rozendaal L, Snijders PJF, et al. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer. 2004;110:94-101.
26. Vousden KH. Human papillomaviruses and cervical carcinoma. Cancer Cells. 1989;1:43-50.
27. Clifford GM, Smith JS. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88:63-73.
28. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119:1095-1101.